Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mem Inst Oswaldo Cruz ; 112(6): 452-455, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28591406

RESUMO

Diagnosis of schistosomiasis in migrants coming from endemic areas can be difficult, especially in asymptomatic subjects. Light-intensity disease, in fact, may be missed due to the low sensitivity of the stool microscopy and serologic testing cannot distinguish between a resolved infection and an active infection in patients who have been infected and treated in the past, because specific antibodies can persist despite cure. We describe a cross-sectional study conducted on 82 migrants tested for Schistosoma mansoni on single blood (anti-schistosome antibodies, total IgE) and urine [point-of-care (POC) circulating-cathodic-antigen (CCA) test] samples. A positive POC-CCA test (active infection) resulted in two untreated patients with a positive serology while all patients (n = 66) with a past infection showed a negative POC-CCA test. POC-CCA urine test in combination with serology may be helpful in rapidly differentiate active from past S. mansoni infection in migrants coming from endemic areas.


Assuntos
Antígenos de Helmintos/análise , Schistosoma mansoni/imunologia , Esquistossomose mansoni/diagnóstico , Migrantes/estatística & dados numéricos , Adulto , Animais , Estudos Transversais , Feminino , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
2.
Mem. Inst. Oswaldo Cruz ; 112(6): 452-455, June 2017. tab
Artigo em Inglês | LILACS | ID: biblio-1040569

RESUMO

ABSTRACT Diagnosis of schistosomiasis in migrants coming from endemic areas can be difficult, especially in asymptomatic subjects. Light-intensity disease, in fact, may be missed due to the low sensitivity of the stool microscopy and serologic testing cannot distinguish between a resolved infection and an active infection in patients who have been infected and treated in the past, because specific antibodies can persist despite cure. We describe a cross-sectional study conducted on 82 migrants tested for Schistosoma mansoni on single blood (anti-schistosome antibodies, total IgE) and urine [point-of-care (POC) circulating-cathodic-antigen (CCA) test] samples. A positive POC-CCA test (active infection) resulted in two untreated patients with a positive serology while all patients (n = 66) with a past infection showed a negative POC-CCA test. POC-CCA urine test in combination with serology may be helpful in rapidly differentiate active from past S. mansoni infection in migrants coming from endemic areas.


Assuntos
Humanos , Animais , Masculino , Feminino , Adulto , Schistosoma mansoni/imunologia , Migrantes/estatística & dados numéricos , Esquistossomose mansoni/diagnóstico , Antígenos de Helmintos/análise , Estudos Transversais , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Itália , Pessoa de Meia-Idade
3.
Infez Med ; 15(1): 59-62, 2007 Mar.
Artigo em Italiano | MEDLINE | ID: mdl-17515677

RESUMO

Strongyloidiasis is caused by a small intestinal nematode with a complex life cycle. In Italy the infection is endemic in rural areas of the Po Valley. The clinical syndrome of S. stercoralis encompasses a broad spectrum of symptoms and signs and, in the immunocompromised host, larvae can migrate to different organs and tissues. Also immune response seems to play a role in the pathogenesis of the disease. We report a case of strongyloidiasis complicated by Gram-negative sepsis and nephrotic syndrome in an immigrant from South America with a normal immune response. Whereas sepsis cleared up quickly, parasitic clearance was obtained only after treatment with ivermectin and nephrotic syndrome was still present three months after the end of treatment.


Assuntos
Bacteriemia/complicações , Infecções por Escherichia coli/complicações , Síndrome Nefrótica/etiologia , Estrongiloidíase/complicações , Adulto , Albendazol/uso terapêutico , Animais , Anti-Helmínticos/uso terapêutico , Antibacterianos/uso terapêutico , Equador/etnologia , Doenças Endêmicas , Infecções por Escherichia coli/tratamento farmacológico , Humanos , Imunocompetência , Itália/epidemiologia , Ivermectina/uso terapêutico , Larva , Masculino , Nefrose Lipoide/etiologia , Prednisona/uso terapêutico , Strongyloides stercoralis/crescimento & desenvolvimento , Estrongiloidíase/tratamento farmacológico , Estrongiloidíase/epidemiologia , Estrongiloidíase/imunologia , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA